Replies to post #3037 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Current Insider Shareholdings and Options

[As of Mar 30, 2007. Options include those
that are exercisable now or within 60 days.]

 
  
 Executive Officers  
 Geoffrey Cox, CEO          242K shares   667K options 
 John Green, CFO            109K shares   291K options 
 Harry Meade, SVP Research  107K shares   240K options 
 Dan Woloshen, Gen. Counsel  81K shares   177K options 
 Greg Liposky, SVP Oprtns    51K shares   224K options 
 Dick Scotland, SVP Regltry  60K shares   129K options 
 -- 
 Six executive officers     650K shares 1,997K options

 
 Independent directors  
 Robert Baldridge             5K shares    60K options 
 Kenneth Bauer                 0 shares    23K options 
 Christian Béchon             3K shares    23k options 
 Francis Bullock              5K shares    66K options 
 James Geraghty              70K shares   148K options 
 Michael Landine               0 shares    15K options 
 Pamela McNamara              6K shares    37K options 
 Marvin Miller                5K shares    38K options 
 Alan Tuck                   11K shares    43K options 
 -- 
 Nine independent directors 105K shares   453K options

 
 All officers/directors     755K shares 2,450K options